IP Library Granted Patent US 7,033,996
Granted Patent B2
US 7,033,996 · App. 10/232,342 · Granted Apr 25, 2006

Method for the treatment of vitamin D related disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,033,996
App. No.
10/232,342
Granted
Apr 25, 2006
Kind
B2
Abstract

The present invention provides a method for treating diseases caused by either an excess or diminution of Vitamin D 3 . It provides pharmaceutical compositions for the treatment of such diseases and the methods by which these compositions are to be used. Also provided are methods for testing the activity of both 24(OH)ase and CCAATT/Enhancer Binding Protein β (C/EBPβ), as well as, for testing the effect of a compound on 24(OH)ase and C/EBPB activity activity. In particular embodiments, a method is provided for reducing the risk of hypercalcemia when administering 1,25(OH) 2 D 3 or its analogs for the treatment of vitamin D diseases. Methods for both enhancing and diminishing 24(OH)ase activity are also provided.

Claims (5)

1. A pharmaceutical composition comprising a C/EBPβ protein, wherein the amino acid sequence coding for the C/EBPβ protein has at least 95% identity to that of SEQ ID NO:2.

2. The pharmaceutical composition according to claim 1 , further comprising a biologically acceptable carrier, wherein the pharmaceutical composition contains an effective amount of said C/EBPβ protein for the treatment of a disease associated with excess 1,25 (OH) 2 D 3 .

3. The pharmaceutical composition according to claim 2 , wherein the disease associated with excess 1,25 (OH) 2 D 3 to be treated is hypercalcemia.

4. A kit, comprising; a container for providing a composition of claim 1 , and either (i) a device for delivering said composition to cells of an organism, wherein said device is capable of being combined with said container, or (ii) instructions explaining how to deliver said composition with said device.

5. A method for making a kit of claim 4 , comprising the steps of combining a container for providing a composition of claim 1 or 3 with a biologically acceptable carrier and either (i) a device for delivering said composition to the cells of an organism, wherein said device is capable of being combined with said container, or (ii) instructions explaining how to deliver said composition with said device.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 5, 2013
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 031170/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2002
From: CHRISTAKOS, SYLVIA
To: UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY
Reel/Frame 013566/0616 →